Methyl 4-(4-hydroxypiperidin-4-yl)benzoate hydrochloride, 97%, 250mg

Methylsulfonylacetonitrile, 98.0%, 5g

5-Bromo-4-methylthiazole, 95.0%, 5g

2-chloro-4-methyl-7,8-dihydro-6H-cyclopenta[g]quinoline, 95.0%, 50g

N-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)phenyl)quinoline-2-carboxamide, 98%, 250mg

Closure clips Spectra/Por® Combi packaging, 55 mm, 20 Piece(s)

4-Bromo-3-nitrobenzoic acid, 97.0%, 5g

5-chloro-1-(3-chlorophenyl)-1-oxopentane, 97.0%, 1g

2-methyl-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxylic acid, 95.0%, 1g

3-Methylpiperidin-4-ol, 95.0%, 250mg

3-(3-Fluorophenyl)benzaldehyde, 97.0%, 5g

3-(CHLOROMETHYL)-5-METHOXYPYRIDINE HYDROCHLORIDE, 95%, 250mg

1-Bromo-3-(2-bromoethyl)benzene, 95.0%, 1g